Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-18T05:15:14.063Z Has data issue: false hasContentIssue false

Biomarkers as Surrogate Endpoints: Ongoing Opportunities for Validation

Published online by Cambridge University Press:  01 January 2021

Rights & Permissions [Opens in a new window]

Abstract

Surrogate endpoints are a common application of biomarkers to estimate clinical benefit in clinical trials, despite questions about reliability. This article discusses ongoing opportunities for their validation, in the context of a regulatory environment in which they are increasingly championed.

Information

Type
Symposium Articles
Copyright
Copyright © American Society of Law, Medicine and Ethics 2019